Cline Scientific adds new advisor for StemCART project
Cline Scientific announces that they have appointed Professor and Orthopedic Surgeon Mats Brittberg as a new advisor for the company’s StemCART project.
Professor Mats Brittberg is currently a member of the Cartilage Research Unit, within the Department of Orthopedics Surgery, at the University of Gothenburg and an orthopedic surgeon at the Kungsbacka Hospital, Sweden. Mats Brittberg’s research has been focused on cartilage repair and with the main focus on cartilage regeneration with autologous chondrocytes. Mats Brittberg has been on the board of TESI (Tissue engineering Society International) and has been the chair of the Cartilage Committee of ESSKA 2006-08. Since 1997, he has worked with ICRS (International Cartilage Regeneration and Joint Repair Society), as Secretary, Vice-president and President (2006-2008), and Past-President (2008-2009). Since January 2013, he has been the Editor-in-Chief of the journal CARTILAGE. He has received several accolades including ICRS Genzyme Lifetime Achievement Award in cartilage research, the United Kingdom Cartilage Club and Shetty-Kim Research Foundation’s scientific Award, Canterbury Christ Church University, and UK Cartilage Club’s Lifetime award in cartilage research. He has also recently received the Lifetime Achievement award from Joint Preservation Congress in Warsaw, Poland.
In collaborating with Professor Brittberg, Cline will gain access to a wealth of experience within the area of cartilage repair, joint preservation, and tissue engineering. Professor Brittberg has been a pioneering figure in developing in vitro expanded autologous chondrocytes implantation and leading research collaborations around the world. Furthermore, his extensive experience as a prominent surgeon in this area will be a great asset as Cline continues their journey to bringing StemCART into clinical trials.
“We are both honored and excited with the addition of Mats Brittberg to our StemCART team. The wealth of knowledge and experience he can bring to the project in both scientific and clinical aspect is certainly invaluable. We warmly welcome Professor Brittberg to join the journey with the StemCART venture!” Says Patrik Sundh, Cline Scientific CEO.
“It is very stimulating to have the opportunity to work with the Cline team on developing new repair methods how to control and guide stem- and progenitor cells into the chondrogenic pathway" Says Professor Mats Brittberg.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 0703585088
Cline Scientific AB (publ) Phone: 031-387 55 55
Argongatan 2 C Email: info@clinescientific.com
431 53 MÖLNDAL Website: www.clinescientific.com
About Cline Scientific
Cline Scientific develops advanced cancer diagnostics and regenerative medicine treatments. The company is working heavily with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The focus is on projects in the cancer diagnostic and stem cell therapy fields since Clines nanotechnology here provides unmet solutions to critical challenges and functions. The unique patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase